Pre-Annual Meeting Seminars

ASCO will offer five in-depth educational opportunities dedicated to topics of interest in the oncology community. Each seminar will be held onsite at McCormick Place, from Thursday, May 28 to Friday, May 29. Seminar topics and preliminary program information can be found below.

The financing and organization of cancer care is shifting dramatically. Today, there is almost daily discussion among policymakers, providers, and payers regarding treatment costs and how best to reward provision of high-quality care. Innovative reimbursement models, treatment pathways, and benefits provide lessons learned and new best practices.Yet, the pace of innovation in these areas is rapid, and many stakeholders are likely affected by such changes including but not limited to payers, providers, and patients. This seminar provides participants with core and emerging knowledge regarding cost and quality drivers in cancer treatment development and provision. The goal of this seminar is to provide participants sufficient background knowledge to make better-informed decisions in their relations with patients and payers.

This seminar will cover current and innovative strategies for rewarding research and development in cancer therapeutics and diagnostics, trends in trial costs, drug pricing, financial burdens placed on patients, the basics of reimbursement and coverage decision-making, lessons from innovative reimbursement, coverage and treatment models, options for reimbursement reform, and defining quality in the outpatient setting.

 

Preliminary Program

Thursday, May 28, 2015

Session 1: Current and future strategies for rewarding research and development in cancer therapeutics and diagnostics (1:00-2:40 PM)
Elad Sharon, MD, MPH — Medical Officer, Senior Investigator of Investigational Drug Branch
National Cancer Institute at the National Institutes of Health
Session Chair, Planning Committee Member

  • Introduction
  • Trends in Cancer Treatment Development and Spending Worldwide
  • Pricing as an Incentive for Investment
  • Credit Markets for the Development of New Treatments and Diagnostics Tests for Cancer
  • Panel Discussion and Q&A

Session 2: Spending on Cancer Care (2:40-4:00 PM)
K. Robin Yabroff, PhD, MBA — Epidemiologist, Health Services and Economics Branch
National Cancer Institute at the National Institutes of Health
Session Chair, Planning Committee Member

  • Introduction
  • National trends in Spending on Cancer Treatment
  • Trends in the Costs and Utilization of Targeted Cancer Therapies
  • Cancer Diagnosis, Treatment and Work
  • Panel Discussion and Q&A

 

 

Friday, May 29, 2015

Session 3: Innovative Reimbursement, Coverage and Treatment Models (7:30-9:30 AM)
Rena M. Conti, PhD — Assistant Professor
The University of Chicago
Session Chair, Planning Committee Chair

  • Introduction
  • The Anthem Pathways Initiative
  • Update on COME HOME, the Oncology Medical Home
  • CMS -- Using an Episode Based Payment Model to Improve Oncology Care
  • Panel Discussion and Q&A

Session 4: Future Reform (9:30-11:00 AM)

  • Introduction
  • Ideal Cancer Payment Bundles: Resurrecting the Center for American Progress
  • Rethinking Drug Acquisition and Coverage
  • Cancer Outcome Measurement:  The Key to Paying for Value in Cancer Care
  • Panel Discussion and Q&A